A Phase II, DoubleBlind, Randomized, Parallel Group, Dose Finding Study of the Safety and Tolerability of Darexaban Compared with Warfarin in Patients with NonValvular Atrial Fibrillation

http://www.medworm.com/index.php?rid=114111635&cid=c_64_19_f&fid=29462&url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fdoi%3FDOI%3D10.1111%252Fjth.13025

Comments are closed.